New hope for a type 2 diabetes cure
A team of scientists has identified a possible use for the leukemia treatment drug Imatinib in treating type 2 diabetes. Gleevec was found to lower insulin resistance by controlling PPARγ, reducing the risk of hyperglycemia and obesity.